Bang CH, Oh HJ, Kim YH, Jung J-H, Lee JH, Park YM, et al. Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors. Acta Derm Venereol [Internet]. 2024 Sep. 9 [cited 2026 Jul. 14];104:adv34206. Available from: https://medicaljournalssweden.se/actadv/article/view/34206